Urinary Lipid Peroxidation Byproducts: Are They Relevant for Predicting Neonatal Morbidity in Preterm Infants?

Area of Science:

• Neonatology
• Biochemistry
• Pediatric Pulmonology

Background:

• Preterm infants (<32 weeks gestation) have immature antioxidant systems and often require supplemental oxygen.
• Oxygen-free radicals contribute to inflammation, morbidity, and mortality in preterm infants.
• Assessing lipid peroxidation byproducts is crucial for evaluating oxidative stress and inflammation.

Purpose of the Study:

• To determine reference ranges for lipid peroxidation byproducts (isoprostanes, isofurans, neuroprostanes, neurofurans) in preterm infants.
• To investigate correlations between these byproducts and neonatal conditions.
• To evaluate the potential of early urinary byproduct levels to predict chronic lung conditions.

Main Methods:

• Analysis of 536 serial urine samples from 254 preterm infants (<32 weeks gestation) within the first 4 weeks of birth.
• Utilized ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS).
• Included data from two randomized, controlled, and blinded clinical trials.

Main Results:

• Established reference ranges for urinary isoprostanes, isofurans, neuroprostanes, and neurofurans.
• Urinary isofuran levels in the first 4 days post-birth correlated with the later development of bronchopulmonary dysplasia.
• No free radical associated conditions were observed in the analyzed cohort.

Conclusions:

• Early urinary determination of lipid peroxidation byproducts, particularly isofurans, may predict the development of chronic lung conditions in preterm infants.
• This finding supports the relevance of metabolite profiling for assessing oxidative stress and inflammation in neonates.
• Highlights potential for early diagnostic markers in high-risk infant populations.